Cargando…
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway
SIMPLE SUMMARY: It has been a continuous effort to develop innovative targeted cancer treatments to overcome the non-specific toxicity associated with chemotherapy. Antibody-drug conjugates (ADCs) highlight the clinical benefits of specifically delivering drugs to cancer cells via targeting agents....
Autores principales: | Song, Xirui, Yu, Haixiang, Sullenger, Cynthia, Gray, Bethany Powell, Yan, Amy, Kelly, Linsley, Sullenger, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136559/ https://www.ncbi.nlm.nih.gov/pubmed/37190227 http://dx.doi.org/10.3390/cancers15082301 |
Ejemplares similares
-
Applications and future of aptamers that achieve rapid-onset anticoagulation
por: Yu, Haixiang, et al.
Publicado: (2023) -
An Aptamer for Broad Cancer Targeting and Therapy
por: Powell Gray, Bethany, et al.
Publicado: (2020) -
Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes
por: Gray, Bethany Powell, et al.
Publicado: (2023) -
Protocol for purification of cells in their native state using reversible aptamer-antidote pairs
por: Requena, Martin D., et al.
Publicado: (2023) -
Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer
por: Puzzo, Francesco, et al.
Publicado: (2023)